We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $15.6B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$1.42B
Cap. Flow
+$81.1M
Cap. Flow %
0.52%
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407

Sector Composition

Rank Sector Weight
1 Industrials 19.5%
2 Financials 16.81%
3 Miscellaneous 15.64%
4 Technology 13.57%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEN icon
976
Wendy's
WEN
$1.53B
$8 ﹤0.01%
1
-56,745
-100% -$406K
UPB
977
Upstream Bio Inc
UPB
$329M
$7 ﹤0.01%
1
ANGI icon
978
Angi Inc
ANGI
$199M
$6 ﹤0.01%
1
MYGN icon
979
Myriad Genetics
MYGN
$305M
$6 ﹤0.01%
+1
New +$5
SOUN icon
980
SoundHound AI
SOUN
$2.99B
$6 ﹤0.01%
+1
New +$8
WEAV icon
981
Weave Communications
WEAV
$586M
$6 ﹤0.01%
1
TMQ
982
Trilogy Metals
TMQ
$570M
$4 ﹤0.01%
+1
New +$4
SLDP icon
983
Solid Power
SLDP
$575M
$3 ﹤0.01%
1
CCO icon
984
Clear Channel Outdoor Holdings
CCO
$1.21B
$2 ﹤0.01%
+1
New +$2
CLVT icon
985
Clarivate
CLVT
$1.32B
$2 ﹤0.01%
1
CMPX icon
986
Compass Therapeutics
CMPX
$429M
$2 ﹤0.01%
+1
New +$3
MVST icon
987
Microvast
MVST
$266M
$2 ﹤0.01%
2
RC
988
Ready Capital
RC
$289M
$2 ﹤0.01%
1
RR icon
989
Richtech Robotics
RR
$394M
$2 ﹤0.01%
1
ALIT icon
990
Alight
ALIT
$398M
0
AAON icon
991
Aaon
AAON
$6.55B
-291,896
Closed -$24.2M
ABBV icon
992
AbbVie
ABBV
$453B
-2
Closed -$435
ABG icon
993
Asbury Automotive
ABG
$3.9B
-1,615
Closed -$316K
ABUS icon
994
Arbutus Biopharma
ABUS
$1.02B
-18,006
Closed -$81K
ACA icon
995
Arcosa
ACA
$7.14B
-1,756
Closed -$186K
ACVA icon
996
ACV Auctions
ACVA
$1.19B
-37,799
Closed -$160K
ADBE icon
997
Adobe
ADBE
$106B
-5,675
Closed -$1.38M
ADEA icon
998
Adeia
ADEA
$2.92B
-18,255
Closed -$439K
ADP icon
999
Automatic Data Processing
ADP
$110B
-141,784
Closed -$28.8M
ADTN icon
1000
Adtran
ADTN
$579M
-7,731
Closed -$97.3K

Similar funds

Freestone Grove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.

  • Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
  • Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
  • Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
  • Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
  • Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
  • Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.